scispace - formally typeset
R

Roger D. Porsolt

Researcher at University College London

Publications -  67
Citations -  7783

Roger D. Porsolt is an academic researcher from University College London. The author has contributed to research in topics: Safety pharmacology & Piracetam. The author has an hindex of 27, co-authored 67 publications receiving 7427 citations.

Papers
More filters
Journal ArticleDOI

Behavioural despair in rats: a new model sensitive to antidepressant treatments.

TL;DR: Positive findings with atypical antidepressant drugs such as iprindole and mianserin suggest that the method may be capable of discovering new antidepressants hitherto undetectable with classical pharmacological tests.
Journal ArticleDOI

Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice.

TL;DR: This simple behavioral procedure has since become a useful test for screening novel antidepressants in rats and is presented in this unit and an equivalent procedure in the mouse is also described along with a "dry” version of the test where immobility is induced simply by suspending the mouse by the tail.
Journal ArticleDOI

“Behavioural despair” in rats and mice: Strain differences and the effects of imipramine

TL;DR: Important differences exist between strains in both the amount of immobility observed and the effects of imipramine, and strain differences should be taken into account in attempts to replicate results from one laboratory to another.
Journal ArticleDOI

Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity.

TL;DR: It was concluded that immobility depended primarily on the activity of central catecholamines but that caution was required before ascribingimmobility exclusively to activity within a single system.
Journal ArticleDOI

Broad-Spectrum, Non-Opioid Analgesic Activity by Selective Modulation of Neuronal Nicotinic Acetylcholine Receptors

TL;DR: In this article, a potent nAChR ligand called ABT-594 was developed that has antinociceptive properties equal in efficacy to those of morphine across a series of diverse animal models of acute thermal, persistent chemical, and neuropathic pain states.